PAPER
Tandem Base-Catalyzed, Triphenylphosphine-Mediated Disulfide Reduction–Michael Addition
2031
(10) (a) Ranu, B.; Dey, S.; Hajra, A. Tetrahedron 2003, 59,
2417. (b) Merajuddin Baag, M.; Sahoo, M.; Puranik, V.;
Argade, N. Synthesis 2007, 457. (c) Hummel, G.; Jobron,
L.; Hindsgaul, O. J. Carbohydr. Chem. 2003, 22, 781.
(d) Kawatsura, M.; Komatsu, Y.; Yamamoto, M.; Hayase,
S.; Itoh, T. Tetrahedron Lett. 2007, 48, 6480. (e) Zhao, Y.;
Ge, Z.; Cheng, T.; Li, R. Synlett 2007, 1529. (f) Hiemstra,
C.; van der Aa, L.; Zhong, Z.; Dijkstra, P.; Feijen, J.
Biomacromolecules 2007, 8, 1548. (g) Nilsson, K.; Mellin,
L.; Nederberg, F.; Bowden, T. Macromolecules 2007, 40,
901. (h) Meciarova, M.; Toma, S. Lett. Org. Chem. 2006, 3,
794. (i) Manickam, G.; Sundararajan, G. Tetrahedron 1999,
55, 2721. (j) Mukherjee, C.; Misra, A. K. J. Carbohydr.
Chem. 2007, 26, 213. (k) Movassagh, B.; Zakinezhad, Y. Z.
Naturforsch., B 2006, 61, 47.
(11) (a) Prabhu, K.; Sivanand, P.; Chandrasekaran, S. Angew.
Chem. Int. Ed. 2000, 39, 4316. (b) Ranu, B. Synth.
Commun. 2007, 37, 1517. (c) Ranu, B.; Mandal, T. Can. J.
Chem. 2006, 84, 762. (d) Ranu, B.; Mandal, T. Synlett 2004,
1239. (e) Friend, C.; Simpkins, N.; Anson, M.; Polywka, M.
Tetrahedron 1998, 54, 2801. (f) Taniguchi, Y.; Maruo, M.;
Takaki, K.; Fujiwara, Y. Tetrahedron Lett. 1994, 35, 7789.
(g) Zheng, X.; Xu, X.; Zhang, Y. Synlett 2003, 2062.
(12) (a) Ogawa, A.; Nishiyama, Y.; Kambe, N.; Murai, S.;
Sonoda, N. Tetrahedron Lett. 1987, 28, 3271. (b)Katritzky,
A. R.; Rogovoy, B. V.; Chassaing, C.; Vvedensky, V.;
Forood, B.; Flatt, B.; Nakai, H. J. Heterocycl. Chem. 2000,
37, 1655.
References
(1) (a) Kanda, Y.; Ashizawa, T.; Kawashima, K.; Ikeda, S.;
Tamaoki, T. Bioorg. Med. Chem. Lett. 2003, 13, 455.
(b) Cai, Z.; Zhou, W.; Sun, L. Bioorg. Med. Chem. 2007, 15,
7809. (c) Tyrkov, A.; Urlyapova, N.; Daudova, A. Pharm.
Chem. J. 2006, 40, 377. (d) Kendall, J.; Rewcastle, G.;
Frederick, R.; Mawson, C.; Denny, W.; Marshall, E.;
Baguley, B.; Chaussade, C.; Jackson, S.; Shepherd, P.
Bioorg. Med. Chem. 2007, 15, 7677. (e) Lombart, H. G.;
Feyfant, E.; Joseph-McCarthy, D.; Huang, A.; Lovering, F.;
Sun, L. H.; Zhu, Y.; Zeng, C. M.; Zhang, Y.; Levin, J.
Bioorg. Med. Chem. Lett. 2007, 17, 4333.
(2) (a) Wang, X.; Guo, Z. Anti-Cancer Agents Med. Chem.
2007, 7, 19. (b) Jacob, C. Nat. Prod. Rep. 2006, 23, 851.
(c) Ariga, T.; Seki, T. BioFactors 2006, 26, 93.
(d) Motohashi, N.; Kawase, M.; Satoh, K.; Sakagami, H.
Curr. Drug Targets 2006, 7, 1055.
(3) (a) Liu, Y.; Zhang, H. Y.; Chen, L. X.; He, X. W.; Wada, T.;
Inoue, Y. J. Org. Chem. 2000, 65, 2870. (b) Yano, T.;
Wasada-Tsutsui, Y.; Arii, H.; Yamaguchi, S.; Funahashi, Y.;
Ozawa, T.; Masuda, H. Inorg. Chem. 2007, 46, 10345.
(c) Calatayud, D.; López-Torres, E.; Mendiola, M. Inorg.
Chem. 2007, 46, 10434. (d) Enders, D.; Klumpen, T.
J. Organomet. Chem. 2001, 637, 698.
(4) van Zanten, A.; Oudijk, M.; Nohlmans-Paulssen, M.; van
der Meer, Y.; Girbes, A.; Polderman, K. Br. J. Clin.
Pharmacol. 2007, 63, 100.
(5) (a) Brown, H. C.; Midland, M. M. J. Am. Chem. Soc. 1971,
93, 3291. (b) Pelter, A.; Pardasani, R.; Pardasani, P.
Tetrahedron 2000, 56, 7339. (c) Kneisel, F.; Knochel, P.
Synlett 2002, 1799.
(6) (a) Munavalli, S.; Rossman, D. I.; Rohrbaugh, D. K.;
Ferguson, C. P. J. Fluorine Chem. 1993, 61, 147.
(b) Munavalli, S.; Rossman, D. I.; Rohrbaugh, D. K.;
Ferguson, C. P. J. Fluorine Chem. 1993, 61, 155.
(c) Negishi, E. In Organometallics in Organic Synthesis;
Wiley: New York, 1980, 243–247.
(13) (a) Danehy, J. P.; Hunter, W. E. J. Org. Chem. 1967, 32,
2047. (b) Maiti, S. N.; Spevak, P.; Singh, M. P.; Micetich, R.
G.; Reddy, A. V. N. Synth. Commun. 1988, 18, 575.
(c) Brown, H. C.; Nazer, B.; Cha, J. S. Synthesis 1984, 498.
(d) Gladysz, J. A.; Wong, V. K.; Jick, B. S. Tetrahedron
1979, 35, 2329. (e) Zhong, W.; Zhang, Y. Tetrahedron Lett.
2001, 42, 3125. (f) Reddy, G. V. S.; Rao, G. V.; Iyengar, D.
S. Synth. Commun. 2000, 30, 859. (g) Singh, R.;
Lamoureux, G. V.; Lees, W. J.; Whitesides, G. M. Methods
Enzymol. 1995, 251, 167.
(7) (a) Menichetti, S.; Nativi, C. In Targets in Heterocyclic
Systems - Chemistry and Properties, Vol. 7; Attanasi, O. A.;
Spinelli, D., Eds.; Società Chimica Italiana: Rome, 2003,
108–139. (b) Bartolozzi, A.; Capozzi, G.; Menichetti, S.;
Nativi, C. Org. Lett. 2000, 2, 251. (c) Bartolozzi, A.;
Capozzi, G.; Menichetti, S.; Nativi, C. Eur. J. Org. Chem.
2001, 2083. (d) Li, G. M.; Niu, S.; Segi, M.; Tanaka, K.;
Nakajima, T.; Zingaro, R. A.; Reibenspies, J. H.; Hall, M. B.
J. Org. Chem. 2000, 65, 6601. (e) Osborn, H. M. I.;
Coisson, D. Mini-Rev. Org. Chem. 2004, 1, 41.
(14) Overman, L. E.; Smoot, J.; Overman, J. D. Synthesis 1974,
59.
(15) The 1H NMR spectra of the isolated products confirmed the
presence of a free hydroxy group as we would expect for
compounds derived by thiol addition. The thiol moiety of 4-
sulfanylphenol is the strongest and the most-reactive
nucleophile in the compound as it has a pKa of 6.8 compared
with the hydroxy group pKa of 12.4. However, the phenol is
still a reactive species that could possibly undergo Michael
addition under basic conditions if the disulfide reduction was
too slow and the more-reactive thiol was not formed quickly
enough. To confirm that the disulfide reduction occurred
first in our protocol and that side products derived from a
phenol addition were not formed, we repeated the
(f) Ogurtsov, V.; Rakitin, O.; Rees, C.; Smolentsev, A.;
Belyakov, P.; Golovanov, D.; Lyssenko, K. Org. Lett. 2005,
7, 791.
(8) (a) Ueda, M.; Uchiyama, K.; Kano, T. Synthesis 1984, 323.
(b) Graybill, B. M. J. Org. Chem. 1967, 32, 2931.
(9) (a) Carlson, R.; Lundstedt, T. Acta Chem. Scand., Ser. B
1987, 41, 164. (b) Lundstedt, T.; Carlson, R.; Shabana, R.
Acta Chem. Scand., Ser. B 1987, 41, 157. (c) Oae, S. In The
Organic Chemistry of Sulfur; Oae, S., Ed.; Plenum: New
York, 1977, 58–63.
experiment reported in entry 1 of Table 1 without adding
triphenylphosphine. In this case, phenol addition was not
observed, even after heating the reaction overnight.
(16) (a) Krapcho, J.; Turk, C. F.; Piala, J. J. J. Med. Chem. 1968,
11, 361. (b) Ohno, S.; Izumi, K.; Mizukoshi, K.; Kato, K.;
Hori, M. Chem. Pharm. Bull. 1983, 31, 1780. (c) Kugita,
H.; Inoue, H.; Ikezaki, M.; Konda, M.; Takeo, S. Chem.
Pharm. Bull. 1971, 19, 595. (d) Tseng, T. C.; Wu, M. J.
Tetrahedron: Asymmetry 1995, 6, 1633.
Synthesis 2008, No. 13, 2023–2032 © Thieme Stuttgart · New York